Other Controls and Reagents
Avanti Polar Lipids 18:1 PI(3,4)P2 1,2-DIOLEOYL-SN
18:1 PI(3,4)P2 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) (ammonium salt) 100ug
Apexbio Technology LLC DLIN-KC2-DMA-1MG
DLin-KC2-DMA (CAS No 1190197-97-7) is a lipid-based nanoparticle formulation commonly used in the field of biomedical research particularly in the delivery of nucleic acids for gene therapy and RNA interference Originating from advancements in lipid nanoparticle technology it functions by encapsulating therapeutic nucleic acids facilitating their cellular uptake and endosomal escape This enables effective delivery into target cells enhancing gene silencing or expression DLin-KC2-DMA exhibits potent activity in vitro typically in the nanomolar to low micromolar range allowing it to be a versatile tool in drug development and screening Its applications extend to various cell models including primary and immortalized cell lines as well as in vivo animal studies where it aids in the evaluation of gene delivery efficacy and safety Experimental concentrations typically depend on the specific research design to ensure optimal results within each study s context
Echelon Biosciences Research Labs PIP BEADS SAMPLE PACK
Echelon Biosciences - PIP Beads sample pack This item is non returnable
Apexbio Technology LLC DLIN-KC2-DMA-10MG
DLin-KC2-DMA (CAS No 1190197-97-7) is a lipid-based nanoparticle formulation commonly used in the field of biomedical research particularly in the delivery of nucleic acids for gene therapy and RNA interference Originating from advancements in lipid nanoparticle technology it functions by encapsulating therapeutic nucleic acids facilitating their cellular uptake and endosomal escape This enables effective delivery into target cells enhancing gene silencing or expression DLin-KC2-DMA exhibits potent activity in vitro typically in the nanomolar to low micromolar range allowing it to be a versatile tool in drug development and screening Its applications extend to various cell models including primary and immortalized cell lines as well as in vivo animal studies where it aids in the evaluation of gene delivery efficacy and safety Experimental concentrations typically depend on the specific research design to ensure optimal results within each study s context
eMolecules 1799317-04-6 | BP Lipid 314 | Broadpharm823.254 | C48H90N2O8 | 95.000 | CCCCCCCCOC(CCC(=O)OCC(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)NCCCN(C)C)OCCCCCCCC | 25mg | 798870892
BP Lipid 314 | Broadpharm | 1799317-04-6823.254 | C48H90N2O8 | 95.000 | CCCCCCCCOC(CCC(=O)OCC(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)NCCCN(C)C)OCCCCCCCC | 25mg | 798870892
Medchemexpress LLC DSPE-PEG2000-Cys-SRNLIDC (disulfide bridge: Cys1-Cys8) | 2000 (Average) | 5 MG
DSPE-PEG2000-Cys-SRNLIDC is a PEG compound composed of DSPE and a cyclic oligopeptide (pPB). The pPB component exhibits a strong binding affinity with PDGFRβ, which is overexpressed on activated hepatic stellate cells (HSC). This compound is suitable for drug delivery applications.
- Composed of DSPE and a cyclic oligopeptide (pPB)
- pPB binds strongly with PDGFRβ
- Suitable for drug delivery
eMolecules BP Lipid 138 | Broadpharm |682.128 | C42H83NO5 | 0.000 | CCCCCCCCCOC(=O)CCCCCN(CCCO)CCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC | 50mg | 672542538
BP Lipid 138 | Broadpharm |682.128 | C42H83NO5 | 0.000 | CCCCCCCCCOC(=O)CCCCCN(CCCO)CCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC | 50mg | 672542538
Medchemexpress LLC Piperazine-1,4-diylbis(ethane-2,1-diyl) (9Z,9'Z,12Z,12'Z)-bis(octadeca-9,12-dienoate) | 3027565-91-6 | 99.0% | 699.10 g·mol⁻¹ | C44H78N2O4 | 10 MG
AA3-DLin is an ionizable cationic lipid used to formulate lipid nanoparticles (LNPs) for mRNA delivery. It has a pKa of 5.8 and is supplied with high purity, making it suitable for research into nucleic acid delivery and vaccine formulation.
- Ionizable cationic lipid with pKa 5.8 to aid endosomal escape.
- High purity (99.0%), suitable for research applications.
- Available in small research quantities for formulation studies.
- Soluble in ethanol at specified concentrations for LNP preparation.
- Suitable for formulation and evaluation of mRNA and other nucleic acid delivery systems.
Avanti Polar Lipids MONOPHOSPHORYL LIPID A 5MG
PHAD™-504 was designed as a synthetic structural analog of detoxified MPLA derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD™, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD™-504 is quite similar to that of PHAD™, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations. purity 99%